Search
for
Sort by
Research 151–180 of 1000+
- Clinical symptoms of hyperandrogenic women diagnosed with COVID‐19
- Case of de novo nail psoriasis triggered by the second dose of Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine
- Hormonal trends in patients suffering from long COVID symptoms
- Testosterone in COVID-19: An Adversary Bane or Comrade Boon
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- COVID ‐19 induced telogen effluvium
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic?
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- The probable destructive mechanisms behind COVID-19 on male reproduction system and fertility
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- The secret identities of TMPRSS2: Fertility factor, virus trafficker, inflammation moderator, prostate protector and tumor suppressor
- Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
- Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection
- COVID-19 Infection: Impact on Hair
- Association between alopecia areata and COVID-19: A systematic review
- Cutaneous Manifestations in COVID-19: Report on 31 Cases from Five Countries
- Alert to US physicians: DHEA, widely used as an OTC androgen supplement, may exacerbate COVID-19
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- Alopecia and severity of COVID-19: a cross-sectional study in Peru
- Comment on “Androgenetic alopecia present in the majority of patients hospitalized with COVID-19”
- Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy)
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Comment on: The Gabrin sign
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Long-term symptom profiles after COVID-19<i>vs</i>other acute respiratory infections: a population-based observational study (COVIDENCE UK)
- Effect of COVID-19 on Hair Diseases Observed by Health Care Providers: Analysis of 513 participants